TY - JOUR AB - Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that several of the panels shown for the cell invasion assays in Figs. 2C and 5D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 19: 1403‑1409, 2019; DOI: 10.3892/mmr.2018.9750] AD - Department of Thyroid Surgery, Hernia and Abdominal Wall Surgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi 030012, P.R. China Department of Gastrointestinal Pancreas, Hernia and Abdominal Wall Surgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi 030012, P.R. China Department of Chest Radiotherapy, Tumor Hospital of Shanxi Province, Taiyuan, Shanxi 030012, P.R. China AU - Zhang,Shuilong AU - Wang,Qiang AU - Li,Dewei AU - Huang,Bo AU - Hou,Xia AU - Wang,Dongliang DA - 2023/02/01 DO - 10.3892/mmr.2022.12910 IS - 2 JO - Mol Med Rep KW - papillary thyroid carcinoma microRNA‑509 proliferation invasion paired box 6 PY - 2023 SN - 1791-2997 1791-3004 SP - 23 ST - [Retracted] MicroRNA‑509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma T2 - Molecular Medicine Reports TI - [Retracted] MicroRNA‑509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma UR - https://doi.org/10.3892/mmr.2022.12910 VL - 27 ER -